Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-24-042965
Filing Date
2024-10-30
Accepted
2024-10-30 06:46:06
Documents
80

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 3047880
2 ex23-1.htm EX-23.1 5066
3 ex107.htm EX-FILING FEES 21726
4 logo_001.jpg GRAPHIC 68479
  Complete submission text file 0001493152-24-042965.txt   13035300

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ppcb-20240630.xsd EX-101.SCH 76304
6 XBRL CALCULATION FILE ppcb-20240630_cal.xml EX-101.CAL 81990
7 XBRL DEFINITION FILE ppcb-20240630_def.xml EX-101.DEF 402862
8 XBRL LABEL FILE ppcb-20240630_lab.xml EX-101.LAB 619140
9 XBRL PRESENTATION FILE ppcb-20240630_pre.xml EX-101.PRE 506486
83 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 1850126
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-282886 | Film No.: 241407364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)